Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.2 to v3.6.3, reflecting a minor site update. It does not modify the study details or visible content.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 in the page footer, indicating a minor platform update. No study data or content visibility are changed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now indicates recruitment is closed and the Intervention/Treatment section has been standardized. New guidance pages were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision was updated to v3.6.0 from v3.5.5.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5. This reflects a minor platform/template update rather than a modification to study details or content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision tag v3.5.4 was added to the page and the previous revision tag v3.5.3 was removed, indicating a release update to the page.SummaryDifference0.1%

- Check71 days agoChange DetectedClinicalTrials.gov has updated its page revision/version number from v3.5.2 to v3.5.3, indicating a platform or display update rather than a change to the underlying study record.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.